Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Strategies to prevent kidney injury from antibiotics in people with cystic fibrosis

Información

DOI:
https://doi.org/10.1002/14651858.CD013032Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 22 mayo 2018see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Fibrosis quística y enfermedades genéticas

Copyright:
  1. Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Naomi Ditchfield

    Department of Respiratory Paediatrics, University Hospitals of the North Midlands, Stoke-on-Trent, UK

  • Francis J Gilchrist

    Academic Department of Child Health, Royal Stoke University Hospital, Stoke-on-Trent, UK

  • Simon J Davies

    Department of Nephrology, University Hospital of North Staffordshire, Stoke-on-Trent, UK

  • Will Carroll

    Correspondencia a: Department of Paediatric Respiratory Medicine, University Hospitals of the North Midlands, Stoke-on-Trent, UK

    [email protected]

Contributions of authors

Roles and responsibilities

TASK

WHO WILL UNDERTAKE THE TASK?

Protocol stage: draft the protocol

FG + ND + WC

Review stage: select which trials to include (2 + 1 arbiter)

ND + WC (+ FG)

Review stage: extract data from trials (2 people)

ND + WC

Review stage: enter data into RevMan

ND

Review stage: carry out the analysis

ND + WC + FG

Review stage: interpret the analysis

ND + WC + FG

Review stage: draft the final review

ND + WC + FG

Update stage: update the review

WC

Sources of support

Internal sources

  • No sources of support provided

External sources

  • National Institute for Health Research, UK

    This systematic review was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group.

Declarations of interest

Naomi Ditchfield has no known potential conflict of interest to declare.

Dr Will Carroll has no known potential conflict of interest to declare.

Dr Francis J Gilchrist has no known potential conflict of interest to declare.

Professor Simon J Davies has no known potential conflict of interest to declare.

Acknowledgements

This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health. The authors are grateful to Jessica Green for her assistance in preparation of the draft protocol.

Version history

Published

Title

Stage

Authors

Version

2018 May 22

Strategies to prevent kidney injury from antibiotics in people with cystic fibrosis

Protocol

Naomi Ditchfield, Francis J Gilchrist, Simon J Davies, Will Carroll

https://doi.org/10.1002/14651858.CD013032

Notes

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.